Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study

Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study

<b>Introduction</b>: Systemic lupus erythematosus (SLE) is associated with infection-related morbidity. The risk of adverse outcomes secondary to infections was exacerbated during the recent COVID-19 pandemic, prompting mass vaccination with the novel mRNA-based and viral-vectored vaccin...

Full description

Saved in:
Bibliographic Details
Main Authors: Giovanni Benanti, Giuseppe A. Ramirez, Tommaso Schioppo, Lorenza Maria Argolini, Gabriella Moroni, Grazia Bonelli, Renato Alberto Sinico, Federico Alberici, Federica Mescia, Luca Moroni, Gabriele D. Gallina, Biancamaria Venerandi, Francesco Tamborini, Chiara Bellocchi, Lorenzo Beretta, Roberto Caporali, Enrica Bozzolo, Lorenzo Dagna, Maria Gerosa
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Vaccines
Subjects:
systemic lupus erythematosus
COVID-19
vaccines
long-term
adverse events
Online Access:https://www.mdpi.com/2076-393X/13/7/735
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/7/735

Similar Items